Background and Scope
MiraCradle® is a cooling device that uses proprietary Phase Change Material (PCM) technology to induce therapeutic hypothermia among newborn suffering from birth asphyxia. The product was developed by Pluss Advanced Technologies in collaboration with CMC (Christian Medical College) Vellore.
Our Approach
- Performed in-depth quantitative and qualitative analysis of Neonatal Intensive Care Units (NICUs) across 30 countries (Latin America, Asia and African countries), with particular focus on determining the clinical need and market potential for Miracradle equipment.
- Comprehensive market analysis reports for target countries
- Compiled a detailed Excel database of companies active in the infant care sector, segmented by each organization’s key priorities, operational footprint, and areas of strategic alignment.
- Developed a targeted outreach presentation (outreach deck) tailored for engagement with business development teams of prioritized infant care companies.
- Undertook systematic analysis—both data-driven and insight-based—to evaluate business environments, regulatory landscapes, and go-to-market barriers/opportunities in each target geography.
Study Output
- SMC supported Pluss Advanced Technologies in devising robust growth strategies to accelerate adoption of their solutions across India as well as developed and developing markets.
- Structured partnership with Draeger for global marketing in 120 countries
- Supported in seeking grant funding by developing an EAD Alliance network for clinical awareness and advocacy for public health adoption